Bioxcel Therapeutics logo

Bioxcel Therapeutics share price today

(BTAI)

Bioxcel Therapeutics share price is $0.43 & -₹0.43 as on 12 Dec 2024, 2.30 'hrs' IST

$0.43

-0.01

(-1.91%)

Market is closed - opens 8 PM, 12 Dec 2024

View live Bioxcel Therapeutics share price in Dollar and Rupees. Guide to invest in Bioxcel Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Bioxcel Therapeutics. Get details on the Indian mutual funds that are investing in Bioxcel Therapeutics. Get Analyst recommendations and forecasts along with all the Bioxcel Therapeutics's financials.

Bioxcel Therapeutics share price movements

  • $0.41
    $0.48

    Day's Volatility :13.86%

  • $0.36
    $4.17

    52 Weeks Volatility :91.48%

Bioxcel Therapeutics Returns

PeriodBioxcel TherapeuticsSector (Health Care)Index (Russel 2000)
3 Months
-21.64%
-8.8%
0.0%
6 Months
-69.43%
-2.7%
0.0%
1 Year
-86.53%
6.5%
0.0%
3 Years
-97.97%
5.6%
-20.0%

Bioxcel Therapeutics Key Statistics

in dollars & INR

Previous Close
$0.4394
Open
$0.45
Today's High
$0.479
Today's Low
$0.4126
Market Capitalization
$21.2M
Today's Volume
$519.6K
52 Week High
$4.17
52 Week Low
$0.3553
Revenue TTM
$2.4M
EBITDA
$-104.3M
Earnings Per Share (EPS)
$-2.04
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1766.94%

How to invest in Bioxcel Therapeutics from India?

It is very easy for Indian residents to invest directly in Bioxcel Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bioxcel Therapeutics stock in both rupees (INR) and dollars (USD). Search for Bioxcel Therapeutics or BTAI on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bioxcel Therapeutics or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bioxcel Therapeutics shares which would translate to -0.023 fractional shares of Bioxcel Therapeutics as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Bioxcel Therapeutics

326%

Period: Sep 12, 2024 to Dec 11, 2024. Change in 30 Days versus previous period

Search volume for Bioxcel Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 12, 2024. 326% more investors are searching Bioxcel Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Bioxcel Therapeutics

  • Vanguard Group Inc

    2.48%

  • BlackRock Inc

    0.91%

  • Geode Capital Management, LLC

    0.62%

  • Wells Fargo & Co

    0.38%

  • Renaissance Technologies Corp

    0.27%

  • Millennium Management LLC

    0.27%

Analyst Recommendation on Bioxcel Therapeutics

Buy

    69%Buy

    30%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Bioxcel Therapeutics(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
10
Hold
4
5
4
Sell
0
0
0

Analyst Forecast on Bioxcel Therapeutics

What analysts predicted

Upside of 1062.79%

Current:

$0.43

Target:

$5.00

Insights on Bioxcel Therapeutics

  • Price Movement

    In the last 7 days, BTAI stock has moved up by 12.8%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 1.10M → 214.0K (in $), with an average decrease of 80.6% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -8.29M → -13.65M (in $), with an average decrease of 64.5% per quarter
  • BTAI vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 46.2% return, outperforming this stock by 132.6%
  • BTAI vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 46.4% return, outperforming this stock by 144.4%
  • Price to Sales

    ForBTAI every $1 of sales, investors are willing to pay $5.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $15.4 for every $1 of sales.

Bioxcel Therapeutics Technicals Summary

Sell

Neutral

Buy

Bioxcel Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Bioxcel Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Bioxcel Therapeutics
-35.19%
-69.43%
-86.53%
-97.97%
-94.74%
Regeneron Pharmaceuticals, Inc.
-5.85%
-24.7%
-11.77%
17.09%
105.58%
Biontech Se
12.25%
24.31%
22.8%
-57.11%
240.97%
Alnylam Pharmaceuticals, Inc.
-5.5%
58.79%
40.79%
36.33%
111.58%
Vertex Pharmaceuticals Incorporated
-4.43%
-2.24%
15.61%
124.98%
113.34%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Bioxcel Therapeutics
NA
NA
NA
-1.57
-17.67
-0.64
NA
-1.89
Regeneron Pharmaceuticals, Inc.
19.27
19.27
1.17
45.03
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.06
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.24
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Bioxcel Therapeutics
Buy
$21.2M
-94.74%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$86.6B
105.58%
19.27
33.61%
Biontech Se
Buy
$28.0B
240.97%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$33.0B
111.58%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$122.1B
113.34%
32.84
-4.51%

About Bioxcel Therapeutics

bioxcel therapeutics, inc. is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence to identify the next wave of medicines across neuroscience and immuno-oncology. the company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. the company's two most advanced clinical development programs are bxcl501, a sublingual thin film formulation designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and bxcl701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer.
Organization
Bioxcel Therapeutics
Employees
74
CEO
Dr. Vimal D. Mehta Ph.D.
Industry
Health Technology

Management People of Bioxcel Therapeutics

NameTitle
Dr. Vimal D. Mehta Ph.D.
Founder, CEO, President, & Director
Mr. Richard I. Steinhart MBA
Senior VP & CFO
Dr. Frank D. Yocca Ph.D.
Senior VP & Chief Scientific Officer
Dr. Vincent J. O'Neill B.Sc., M.D., M.R.C.P.
Executive VP and Chief of Product Development & Medical Officer
Dr. Chetan D. Lathia Ph.D.
Senior VP and Head of Translational Medicine, Clinical Pharmacology & Regulatory Affairs
Dr. Robert Risinger M.D.
Chief Medical Officer - Neuroscience

Important FAQs about investing in Bioxcel Therapeutics from India :

What is Bioxcel Therapeutics share price today?

Bioxcel Therapeutics (BTAI) share price today is $0.43.

Can Indians buy Bioxcel Therapeutics shares?

Yes, Indians can invest in the Bioxcel Therapeutics (BTAI) from India.

With INDmoney, you can buy Bioxcel Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Bioxcel Therapeutics at zero transaction cost.

How can I buy Bioxcel Therapeutics shares from India?

It is very easy to buy Bioxcel Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bioxcel Therapeutics be purchased?

Yes, you can buy fractional shares of Bioxcel Therapeutics with INDmoney app.

What are the documents required to start investing in Bioxcel Therapeutics stocks?

To start investing in Bioxcel Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Bioxcel Therapeutics

Today’s highest price of Bioxcel Therapeutics (BTAI) is $0.48.

Today’s lowest price of Bioxcel Therapeutics (BTAI) is $0.41.

What is today's market capitalisation of Bioxcel Therapeutics

Today's market capitalisation of Bioxcel Therapeutics BTAI is 21.2M

What is the 52 Week High and Low Range of Bioxcel Therapeutics

  • 52 Week High

    $4.17

  • 52 Week Low

    $0.36

How much percentage Bioxcel Therapeutics is down from its 52 Week High?

Bioxcel Therapeutics (BTAI) share price is $0.43. It is down by 89.69% from its 52 Week High price of $4.17.

How much percentage Bioxcel Therapeutics is up from its 52 Week low?

Bioxcel Therapeutics (BTAI) share price is $0.43. It is up by 21.02% from its 52 Week Low price of $0.36.

What are the historical returns of Bioxcel Therapeutics?

  • 1 Month Returns

    -35.19%

  • 3 Months Returns

    -69.43%

  • 1 Year Returns

    -86.53%

  • 5 Years Returns

    -94.74%

Who is the Chief Executive Officer (CEO) of Bioxcel Therapeutics

Dr. Vimal D. Mehta Ph.D. is the current Chief Executive Officer (CEO) of Bioxcel Therapeutics.